Figure S1 from Population-based Screening for <i>BRAF</i><sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
crossref（2023）
摘要
Kaplan-Meier estimation of (A) overall survival of BRAFV600E mCRC NGS cohorts and (B) progression free survival of BRAFV600E mCRC NGS cohorts from BC Cancer and MD Anderson shows no difference in overall or progression free survival.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要